Letters
Cardiovascular diseases
Volume 190 - Issue 5

High levels of confusion for cholesterol awareness campaigns

Author:  Danika V Hall

Med J Aust 2009; 190 (5): 284-285. || doi: 10.5694/j.1326-5377.2009.tb02403.x
Published online: 2 March 2009
Download PDF (71 KB)
Share: Share on Blue Sky Share on Facebook Share on LinkedIn Share by email

In reply: My article1 was submitted for debate when two separate, industry-sponsored cholesterol awareness campaigns were simultaneously targeting the Australian public. There is potential for public confusion following exposure to concurrent campaigns with differing sponsors, creative techniques, and messages such as “Test the Nation”. My article did not diminish the importance of cholesterol screening (nor of the prevention of or treatment for hyperlipidaemia), and indeed it reiterated the National Heart Foundation guidelines. Its intent was to raise debate about industry-sponsored disease awareness campaigns, as there is growing concern in Australia about “disease mongering”2 and the evidence that this is occurring in the cholesterol market in the United States.3

I agree with Sullivan that the Australian public needs education about asymptomatic risk factors, including hypertension and hyperlipidaemia. Ideally, this would include clear information and non-emotive marketing techniques to convey who is most at risk, as well as transparent disclosure of sponsor interests.4 Contrary to Sullivan’s charge, I believe there are many opportunities for quality health education and behaviour change programs, several of which the Centre for Health Initiatives is currently undertaking.5 The intent of my article was to generate critical analysis of industry-sponsored campaigns in order to improve their public health benefit.

Author

  • Danika V Hall1
  • 1. Centre for Health Initiatives, University of Wollongong, Wollongong, NSW.

Correspondence: dh14@uow.edu.au

References

View this article on Wiley Online Library

More like this

View more